US pharma giant Pfizer (NYSE: PFE) reported financial results for the third quarter of 2025 on Tuesday. Revenues for the ...

The bidding war for US obesity focused biotech Metsera, which has attracted offers from Pfizer and Novo Nordisk , and ...

German pharma major Boehringer Ingelheim has broadened its collaboration with Swiss biotech CDR-Life through a global licensing agreement for CDR111, a trispecific M-gager designed to treat autoimmune ...

Italy based clinical-stage biotech AAVantgarde Bio today announced the successful closing of a $141 million (122 million ...

In a further step in South Korea-based Celltrion’s ambitions to diversify from its core biosimilars focus, the company has ...

US pharma major Eli Lilly has revealed plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, ...

UK biotech Slingshot Therapeutics, part of the Syncona Accelerator, has expanded its senior team with the appointments of John Isaac as chief scientific officer and Bobby Soni as chief business ...

The US Food and Drug Administration (FDA) has approved Belgium drugmaker UCB’s Kygevvi (doxecitine and doxribtimine) powder ...

US biopharma Vertex Pharmaceuticals has reported consolidated financial results for the third quarter of 2025 and refined its ...

US pharma giant Merck & Co, known as MSD outside of the USA and Canada, today announced that the company, through subsidiary ...

Swiss specialty drugmaker Santhera Pharmaceuticals saw its shares rise 5.8% to 10.90 francs today, after it reported positive ...

Tuesday is shaping up to be another dark day in the stock market for US genetic medicines company Sarepta Therapeutics as key ...